Co-Producer
|
|
| JuLY
8, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
|
BIG4BIO
CEO WEEKLY Q&A:
Jehee Suh, CEO, Inocras |
In
this Q&A, Suh discusses what drew him
to Inocras, why whole-genome analysis is
approaching an inflection point, how
Inocras is building the evidence base for
broader clinical adoption, and what it
will take for whole-genome-based care to
become the new standard in oncology and
rare disease. More
|
|
|
|
|
Join
us September 30 – October 1 for
LSPA’s largest partnering event of
the year. Connect with the life
sciences ecosystem throughout the
Commonwealth and beyond, get the
latest information through timely
panel discussions and learn about
the newest innovations shaping the
industry.
|
|
Learn More
→ |
|
|
- UroGen: FDA Clearance of the IND for
UGN-501, an Investigational Next-Generation
Oncolytic Virus for Non-Muscle Invasive
Bladder Cancer More
- Wistar: New Apprenticeship Cohort Helps Life
Science Employers Build Skilled Talent
Pipeline More
|
|
 |
|
Investment Banking Advisory to the
Life Science Industry |
|
Learn More
→ |
|
|
- AstraZeneca Pens $2.1B Sino Deal for
Challenger to Merck's COPD Drug Ohtuvayre More
More*
- BioPharmCatalyst Weekly Watchlist: Key PDUFA
and regulatory catalysts for the next 6 months
More
- More on Fore Biotherapeutics Securing
$67M in One of Year's Largest Biotech
Funding Rounds More*
- Penn Medicine: Novel Medicine for Rare
Disease Prompts $10M Gift for Trials More
|
|
 |
Pace®
Life Sciences
The CDMO That Takes You Further.
Your partner for Product
Development, Manufacturing,
Analytical Testing, Regulatory
Consulting & Operational
Support. |
|
Learn More
→ |
|
|
- A Decade on the Map: How Big4Bio’s
Regions Moved in GEN’s Top 10 Biopharma
Clusters, 2016–2026 More
- Big4Bio CEO Weekly Q&A: Jehee
Suh, CEO, Inocras More
- More on Bristol Laying Out KRAS Med
Krazati's Stumble in Confirmatory Colorectal
Cancer Trial More
- More on Certara, Silo Pharma Advancing AI
Agent Strategies With Nvidia Initiatives More*
- Penn Vet: Gene Therapy Study Advances
Another Potential Treatment for Rare Inherited
Blinding Disease Into Human Clinical Trial More
- Subscribe to LifeSci Startup for
Updates on US Startups More
- ZoBio: Expert Q&A More
|
|
 |
| Life
Sciences Talent and Consulting
Strategist George Quinn Named
Partner, Fractional Talent at
Slone Partners |
|
Learn More
→ |
|
|
- Avacta: Appoints Healthcare Executive
Patrick Vink as Deputy Chairman of the Board
of Directors More
- ICYMI: A View from the Trenches - Biotech
Series A in 2026 More
- ICYMI: Fierce Biotech Layoff Tracker 2026:
BioCryst Ends Internal Programs; Biogen Sheds
Apellis R&D Roles More
- ICYMI: Uniquity Bio Welcomes Matthew
Hartzell as Chief Financial Officer More
- OPPORTUNITY: Chief Executive Officer,
Cambridge, MA More
- OPPORTUNITY: Chief Financial Officer, Pine
Brook, NJ / Hybrid More
- OPPORTUNITY: Vice President, Global BD,
Remote More
- Slone Partners: How to De-Risk
Executive Hiring Decisions in Life Sciences
and Healthcare More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Philadelphia Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Philadelphia,
all rights reserved 2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
